vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
34.01
-0.38 (-1.10%)
Feb 12, 2026, 9:36 AM EST - Market open
vTv Therapeutics Employees
vTv Therapeutics had 23 employees as of December 31, 2024. The number of employees increased by 7 or 43.75% compared to the previous year.
Employees
23
Change (1Y)
7
Growth (1Y)
43.75%
Revenue / Employee
$739
Profits / Employee
-$1,020,435
Market Cap
422.03M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 23 | 7 | 43.75% |
| Dec 31, 2023 | 16 | 3 | 23.08% |
| Dec 31, 2022 | 13 | 4 | 44.44% |
| Dec 31, 2021 | 9 | -16 | -64.00% |
| Dec 31, 2020 | 25 | -1 | -3.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 368 |
| REGENXBIO | 353 |
| Kyverna Therapeutics | 129 |
| Enanta Pharmaceuticals | 120 |
| Niagen Bioscience | 104 |
| Lineage Cell Therapeutics | 77 |
| Assembly Biosciences | 73 |
| PureTech Health | 56 |
VTVT News
- 10 days ago - vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737 - GlobeNewsWire
- 7 weeks ago - vTv Therapeutics and M42's IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health - GlobeNewsWire
- 3 months ago - vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - vTv Therapeutics Announces New Appointments to its Scientific Advisory Board - GlobeNewsWire
- 5 months ago - vTv Therapeutics Will Participate in INNODIA Symposium at the EASD 61st Annual Meeting - GlobeNewsWire
- 5 months ago - UPDATE -- vTv Therapeutics to Participate in Upcoming September Investor Conferences - GlobeNewsWire
- 5 months ago - vTv Therapeutics to Participate in Upcoming September Investor Conferences - GlobeNewsWire
- 5 months ago - vTv Therapeutics Announces $80 Million Private Placement with Leading Healthcare Institutional Investors and the T1D Fund - GlobeNewsWire